Your browser doesn't support javascript.
loading
Effect of high frequency repetitive transcranial magnetic stimulation (rTMS) on the balance and the white matter integrity in patients with relapsing-remitting multiple sclerosis: A long-term follow-up study.
Yassine, I A; Shehata, H; Hamdy, S; Abdel-Naseer, M; Hassan, T; Sherbiny, M; Magdy, E; Elmazny, A; Shalaby, N; ElShebawy, H.
Afiliação
  • Yassine IA; Faculty of Medicine, Suez Canal University, Ismailia, Egypt. Electronic address: dr_imaneyassine@med.suez.edu.eg.
  • Shehata H; Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Hamdy S; Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Abdel-Naseer M; Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Hassan T; Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Sherbiny M; Police Hospitals, Cairo, Egypt.
  • Magdy E; Police Hospitals, Cairo, Egypt.
  • Elmazny A; Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Shalaby N; Faculty of Medicine, Cairo University, Cairo, Egypt.
  • ElShebawy H; Faculty of Medicine, Cairo University, Cairo, Egypt.
Mult Scler Relat Disord ; 83: 105471, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38295628
ABSTRACT

OBJECTIVES:

Repetitive Transcranial Magnetic Stimulation (rTMS) is considered as a safe and non-invasive developing technique used as a therapeutic method for patients with Relapsing-Remitting Multiple Sclerosis (RRMS) who suffer from disturbances in gait and balance. The aim of our study is to evaluate the long-term effect of high frequency rTMS as a therapeutic option for truncal ataxia in RRMS patients and to assess its impact on the integrity of the white matter (WMI), measured in the form of anisotropy metrics using diffusion tensor imaging (DTI).

METHODS:

The study was conducted in two phases phase I; a randomized, single-blind, sham-controlled phase and phase II was a 12 months longitudinal open-label prospective phase. Phase I of the trial involved the randomization of 43 patients with RRMS and truncal ataxia to either real (n = 20) or sham (n = 19) rTMS (2 participants from each treatment group were excluded from the study; one developed a relapse before treatment, 2 declined to participate, and one did not show up). Phase II involved providing 12 actual treatments cycles to all patients; each cycle length is 4 weeks, repeated four times on a trimonthly basis, forming a total of 48 sessions. DTI was used for assessment of the WMI. All patients performed DTI 3 times Imaging sessions were conducted at the screening visit, at the end of phase I, and after the last session in phase II for the first, second and third sessions respectively. A figure-of-8-shape coil, employing rTMS protocol and located over the cerebellum, was used. rTMS protocol is formed of 20 trains formed of 50 stimuli with 20 s apart (5 Hz of 80 % of resting Motor Threshold "MT"). The Berg Balance Scale (BBS), Time up and go (TUG) test, and 10-m walk test (10MWT) were first evaluated at the start of each cycle and just after the final rTMS session.

RESULTS:

The genuine rTMS group's 10MWT, TUG, and BBS showed substantial improvement (p < 0.01), which is continued to be improved throughout the study Timeline, with a significant difference observed following the final rTMS session (P< 0.001). A longitudinal increase in FA was observed in both the Cerebello-Thalamo-Cortical (CTC) and Cortico-Ponto-Cerebellar (CPC) bilateral, as indicated by means of Fractional Anisotropy (FA) measures (p < 0.05).

CONCLUSION:

In ataxic RRMS patients, high frequency rTMS over the cerebellum has a long-term beneficial impact on both balance and WMI.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Substância Branca / Esclerose Múltipla Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Substância Branca / Esclerose Múltipla Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2024 Tipo de documento: Article